Cargando…
High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study
BACKGROUND: Work productivity (WP) loss includes absence from work (absenteeism) and productivity loss while working (presenteeism), which leads to high indirect costs in inflammatory bowel disease (IBD). Prior health economic analyses predominantly focused on absenteeism. Here we focus on presentee...
Autores principales: | van Gennep, Sara, Evers, Sanne W, Rietdijk, Svend T, Gielen, Marieke E, de Boer, Nanne K H, Gecse, Krisztina B, Ponsioen, Cyriel I J, Duijvestein, Marjolijn, D’Haens, Geert R, de Boer, Angela G E M, Löwenberg, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885332/ https://www.ncbi.nlm.nih.gov/pubmed/32378704 http://dx.doi.org/10.1093/ibd/izaa082 |
Ejemplares similares
-
Impaired Quality of Working Life in Inflammatory Bowel Disease Patients
por: van Gennep, Sara, et al.
Publicado: (2020) -
Next-Generation Therapeutics for IBD
por: Löwenberg, Mark, et al.
Publicado: (2015) -
Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm
por: Bots, S, et al.
Publicado: (2021) -
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial
por: Löwenberg, Mark, et al.
Publicado: (2023) -
Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
por: Volkers, Adriaan, et al.
Publicado: (2022)